IntraCellular Therapies (ITCI)
(Delayed Data from NSDQ)
$73.26 USD
+1.13 (1.57%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $73.35 +0.09 (0.12%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth A Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/2/24 |
---|---|
Current Quarter | -0.31 |
EPS Last Quarter | -0.30 |
Last EPS Surprise | 31.82% |
ABR | 1.40 |
Earnings ESP
|
-11.29% |
---|---|
Current Year | -0.59 |
Next Year | 0.90 |
EPS (TTM) | -1.46 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 141.92M | 159.98M | 662.67M | 889.85M |
# of Estimates | 5 | 5 | 5 | 5 |
High Estimate | 145.20M | 165.00M | 681.10M | 962.40M |
Low Estimate | 137.10M | 155.90M | 651.96M | 791.77M |
Year ago Sales | 95.31M | 110.79M | 464.37M | 662.67M |
Year over Year Growth Est. | 48.91% | 44.40% | 42.70% | 34.28% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.31 | -0.22 | -0.59 | 0.90 |
# of Estimates | 6 | 5 | 8 | 7 |
Most Recent Consensus | -0.48 | -0.32 | -0.82 | 1.35 |
High Estimate | -0.24 | -0.14 | -0.29 | 1.85 |
Low Estimate | -0.48 | -0.32 | -0.82 | -0.43 |
Year ago EPS | -0.46 | -0.45 | -1.46 | -0.59 |
Year over Year Growth Est. | 32.61% | 51.11% | 59.59% | 251.18% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 1 | 2 | 0 |
Up Last 30 Days | 3 | 3 | 4 | 2 |
Up Last 60 Days | 3 | 3 | 4 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 1 |
Down Last 30 Days | 1 | 1 | 0 | 2 |
Down Last 60 Days | 1 | 1 | 0 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.31 | -0.22 | -0.59 | 0.90 |
7 Days Ago | -0.32 | -0.23 | -0.62 | 0.90 |
30 Days Ago | -0.33 | -0.24 | -0.65 | 0.93 |
60 Days Ago | -0.33 | -0.24 | -0.65 | 0.93 |
90 Days Ago | -0.39 | -0.32 | -0.72 | 0.77 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.35 | -0.21 | -0.55 | 0.74 |
Zacks Consensus Estimate | -0.31 | -0.22 | -0.59 | 0.90 |
Earnings ESP | -11.29% | 5.09% | 6.53% | -17.16% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.30 | -0.25 | -0.45 | -0.46 | NA |
Estimate | -0.44 | -0.59 | -0.62 | -0.63 | NA |
Difference | 0.14 | 0.34 | 0.17 | 0.17 | 0.21 |
Surprise | 31.82% | 57.63% | 27.42% | 26.98% | 35.96% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more